Login / Signup

Hypothalamic corticotrophin releasing hormone neurons in stress-induced psychopathology: Revaluation of synaptic contributions.

Laura M StantonAidan J PriceElizabeth E Manning
Published in: Journal of neuroendocrinology (2023)
Stress has a strong influence on mental health around the world. Decades of research has sought to identify mechanisms through which stress contributes to psychiatric disorders such as depression, to potentially guide the development of therapeutics targeting stress systems. The hypothalamic pituitary adrenal (HPA) axis is the key endocrine system that is responsible for coordinating body-wide changes that are necessary for survival under stress, and much of the research aimed at understanding the mechanisms by which stress contributes to depression has focussed on HPA axis dysfunction. Corticotrophin releasing hormone (CRH) neurons in the paraventricular nucleus of the hypothalamus (PVN) sit at the apex of the HPA axis, integrating signals relevant to stress and external threats, to ensure HPA axis activity is appropriate for the given context. In addition to this, emerging research has demonstrated that neural activity in PVN CRH neurons regulates stress related behaviours via modulation of downstream synaptic targets. This review will summarize convergent evidence from preclinical studies on chronic stress and clinical research in mood disorders demonstrating changes in PVN CRH neural function, consider how this may influence synaptic targets of PVN CRH neurons, and discuss the potential role of these PVN CRH synaptic pathways in the development of maladaptive behaviours following chronic stress that are relevant to depression. We will also highlight important questions for future research aimed at precisely dissecting endocrine and synaptic roles of PVN CRH neurons in chronic stress, their potential interactions, and therapeutic opportunities for the treatment of stress related disorders.
Keyphrases
  • stress induced
  • mental health
  • spinal cord
  • depressive symptoms
  • cancer therapy
  • prefrontal cortex
  • mesenchymal stem cells
  • drug delivery